2.125mg tirzepatide Order (120 mg) Compounded Tirzepatide
Description
GLP-1 medications (Zepbound, Wegovy) produce significantly greater long-term weight loss, have metabolic and cardiovascular benefits, are approved for chronic use, and are more appropriate for patients with obesity-related health conditions who need ongoing treatment
Comprehensive Wellness: Favourable changes in adiponectin, leptin, triglycerides, and waist circumference
Most patients make a full recovery
Economic pressures on healthcare support treatments that improve metabolism in a wide range of ways
Industry analysts project a potential launch in 2028, though timelines could shift depending on regulatory review
Am J Gastroenterol 2022
